Doxofylline Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 200 mg, 400 mg
Reference Brands: Doxolin, Respiridox(India)
Category:
Respiratory Disorder
Doxofylline Tablet is a bronchodilator used to treat asthma and COPD by relaxing airway muscles. Common in India under brands like Doxolin® and Synasma®, it’s available in 200 mg and 400 mg strengths. Doxofylline offers effective relief with fewer side effects than theophylline.
Doxofylline Tablet is available in Tablet
and strengths such as 200 mg, 400 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Doxofylline Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Doxofylline Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Doxofylline Tablet is a modern bronchodilator used to treat asthma, chronic bronchitis, and COPD. It belongs to the methylxanthine class but offers better tolerability and fewer side effects compared to theophylline. Doxofylline works by relaxing airway muscles, improving airflow, and easing symptoms like wheezing and breathlessness. Commonly available in India in 200 mg and 400 mg strengths, it is sold under trusted brands like Doxolin®, Synasma®, Doxovent®, and Respiridox®. Though not FDA-approved in the US, it is widely prescribed in India and other countries for long-term respiratory management. It is available in tablet and syrup forms.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing